- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Artificial intelligence useful in accurately predicting survival in larynx squamous cell carcinoma
South Korea: Cancer is one of the leading causes of death worldwide. A recent study has found that by leveraging emerging technologies, the use of AI (artificial intelligence) in the screening and diagnosing of cancer helps predict the survival rate more accurately and improves patient outcomes with larynx squamous cell carcinoma (LSCC).
In the study, a deep neural network (DNN) with multi-class was revealed to be a suitable method for survival prediction. AI analysis may predict survival more accurately and improve oncologic outcomes.
Choi N and team conducted a single-centre, retrospective study to investigate the potential survival rates of 1026 patients with larynx squamous cell carcinoma (LSCC) who received definitive treatment from 2002 to 2020. This article has been published in Scientific reports.
Researchers in this study aim to develop a survival prediction model using deep neural network (DNN) with multi-classification and regression, random survival forest (RSF), and Cox proportional hazards (COX-PH) model for prediction of overall survival for patients with laryngeal squamous cell carcinoma (LSCC) treated in a single tertiary centre. Also, various clinical factors should be considered when predicting the survival of LSCC patients.
The review found that
- The average concordance indices of survival period predictions were 0.747 ± 0.009 from COX-PH, 0.596 ± 0.015 from RSF, 0.893 ± 0.017 from DNN regression, and 0.859 ± 0.018 from DNN multi-classification.
- The average mortality was 0.682 ± 0.055 with DNN regression and 0.841 ± 0.020 with DNN multi-classification.
- Using a DNN with multi-classification showed significantly better prediction performance than a DNN model with only T/N staging, shown to be an appropriate method for survival prediction.
From the findings collected, the authors concluded that AI technology helps to improve the predictive performance of survival models in LSCC and is more accurate in survival prediction than conventional models. Therefore, AI seems to be concretely detecting the spread of various cancer in the body, predicting survival more accurately and improving oncologic outcomes.
Reference:
Choi, N., Kim, J., Yi, H. et al. The use of artificial intelligence models to predict survival in patients with laryngeal squamous cell carcinoma. Sci Rep 13, 9734 (2023).
https://doi.org/10.1038/s41598-023-35627-1
Dr. Chumbeni E Lotha has completed her Bachelor of Pharmacy from RIPANS, Mizoram and Doctor of Pharmacy from SGRRU,Dehradun. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751